Join us @NYULangoneLI for a FREE #MensHealthMonth community event, including expert talks on prostate & colorectal cancer, heart & bone health, sleep, fertility, weight loss & more. RSVP: i.nyulangone.org/v6p @drsherv @_ChrisKelly @UroOncologist @RadioDoctorKatz @valaryraup

Thank you, #KevinZorn, #DavidCuellar, #BrianHelfand, #ChristopherKelly, #RaviMunver, MD for sharing your invaluable insights on Aquablation® therapy with surgeons nationwide! We are thrilled to have hosted the first PROCEPT BioRobotics® Prostate Innovation Forum in Chicago, where we explored multiple topics in prostate health and why Aquablation therapy is setting a new standard of care for BPH. “We all benefit when we learn from each other. It is a privilege to share the value many of us find with Aquablation® therapy – the ability to provide a predictable, reproducible, and scalable procedure for an ever-growing BPH patient population.” Kevin Zorn, MD #AquablationTherapy #BPH

NASDAQ welcomed PROCEPT BioRobotics® back to New York City to celebrate being one of the world’s fastest-growing surgical robotics companies! We're thrilled to see Aquablation® therapy rapidly becoming the standard of care for BPH, and revolutionizing treatment for patients. 🚀 Q3 2024 Highlights for PROCEPT BioRobotics 🚀 It’s been an exciting quarter as we continue to advance in the field of BPH treatment! Here are some standout achievements from Q3: • Strong momentum accelerating adoption, reflected in our Q3 earnings • Launch of the HYDROS™ Robotic System, the next generation surgical platform • Celebrated 3-year IPO anniversary • Aggregate gross proceeds of approximately $175 million in capital to fuel strategic growth Here’s to more milestones and making a meaningful impact in the urology space! #PROCEPTBioRobotics #NASDAQ #Aquablation #BPH #SurgicalInnovation #Movember bit.ly/3TChpkT

Fantastic first two presentations inaugurating @NYSAUA Marrakesh by our very own @NYUUrology Drs. James Wysock on the ExoDx test for high grade prostate cancer risk assessment and Katie Murray on non muscle invasive bladder cancer.

Great presentation by Dr @_ChrisKelly about Aquablation at @NYSAUA annual meeting in Marrakesh

Join me at the Procept BioRobotics Hands-On Workshops! It's a fantastic chance for surgeons interested in #Aquablationtherapy to get hands-on experience with the robotic system and engage with peers like me who actively perform Aquablation therapy.

Did you know that Procept BioRobotics is conducting clinical research with Aquablation Therapy in men with localized prostate cancer (grade group 1 or 2). If you live in the New York, Chicago, or Los Angeles area, please contact one of our participating centers. The use of product in this clinical study is limited by United States law to investigational use. For more information about the study please click the link below. bit.ly/3SWK5o0

Announcement to the future urologists out there. Check out ✅ this rare opportunity to join @NYUUrology @NYUUROresidency for learning, operating, and making colleagues in a great location. @AmerUrological @UroAcademic 🗽💫😷

A clinical trial led by researchers at @Perlmutter_CC is studying the efficacy of aquablation therapy as a treatment option for patients with an enlarged prostate and localized prostate cancer. Learn more: bit.ly/3sEaTPv

An innovative multi-center study, led by our urologic oncologist Dr. Hebert Lepor of @NYUUrology, is studying the efficacy of #aquablation focal therapy in localized #prostatecancer. Learn about this minimally invasive treatment approach: bit.ly/4a50gpC

Time for a crash course in Anatomy 101! Dr. Kelly's stepping up to decode the mystery behind prostates. Curious about BPH? Discover what it is and how to tackle it head-on: bit.ly/3RG5Ub4 “Not all patients will experience the same results.” #ProstateHealthMonth

This was such a fun session to be a part of. Learning from the best of the best @FaltasLab @SurenaMatinMD @HougenHY @Dr_Jen_Linehan @JCensits. Also look at all those #WUO members on the podium! Thx @UroOnc for recognizing and being inclusive.

Provocative study of radical prostatectomy without prior biopsy for patients w/ PSA>10 high suspicion MRI/PSMA PET. All patients had clinically significant #prostatecancer on final pathology. No data yet if avoiding biopsy impacts functional outcomes -Stief #aaeu23

Fun crew to support the @NYSAUA and @DrLaMontBarlow @NYUUrology. Great event raising awareness for Young Urologists!

Great event and business meeting of the @NYSAUA @AmerUrological last night. We got to celebrate the career of Dr Lepor with friends and colleagues around the section and @NYUUrology.

Bladder diverticulum pathogenesis in 3 seconds.

The future of @NYUUrology looking bright! @vyomsawhney1120 @sidambulkar @NYUUROresidency

Congrats to our incoming NYU FPMRS fellows for 2024! @nadege_A2011 @DoraJSchwartzMD @NYUUrology @PelvicMedicine @nyulangone

I waited for the month to be over but this is the starting @NYUUROresidency team July 2023 at Bellevue @NYCHealthSystem!

Happy first day to our new FPMRS fellow @anjalikapurmd !! A quick pic with Spot is a must. @NYUUrology @PelvicMedicine @Nirit69 @LaurenStewartMD